Dermatan sulphate, heparin cofactor II, and F1+2 peptide in non-insulin-dependent diabetes mellitus

被引：3

作者：

Mascia, F

Paoletti, P

Mameli, G

Mamusa, AM

Cirillo, R

Marongiu, F

机构：

[1] Univ Cagliari, Dipartimento Sci Med, Cagliari, Italy

[2] Div Ematol, Cagliari, Italy

来源：

THROMBOSIS RESEARCH | 2000年 / 97卷 / 04期

关键词：

dermatan sulphate; heparin cofactor II; F1+2 peptide; NIDDM;

D O I：

10.1016/S0049-3848(99)00167-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：263 / 265

页数：3

共 14 条

[1] SEX DIFFERENTIAL IN ISCHEMIC-HEART-DISEASE MORTALITY IN DIABETICS - A PROSPECTIVE POPULATION-BASED STUDY [J].

BARRETTCONNOR, E ;

WINGARD, DL .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 118 (04) :489-496

[2]

BIONDI G, 1991, THROMB HAEMOSTASIS, V66, P267

[3]

CERIELLO A, 1990, HAEMOSTASIS, V20, P357

[4] HEPARIN-COFACTOR-II IN DIABETIC-PATIENTS [J].

DUBOSCQ, C ;

QUINTANA, I ;

BARROS, J ;

KORDICH, L .

BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (02) :201-204

[5]

DUPOUY D, 1988, THROMB HAEMOSTASIS, V60, P236

[6] FIBRINOPEPTIDE-A IN DIABETES-MELLITUS - RELATION TO LEVELS OF BLOOD-GLUCOSE, FIBRINOGEN DISAPPEARANCE, AND HEMODYNAMIC-CHANGES [J].

JONES, RL .

DIABETES, 1985, 34 (09) :836-843

[7] DIABETES, FIBRINOGEN, AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM EXPERIENCE [J].

KANNEL, WB ;

DAGOSTINO, RB ;

WILSON, PWF ;

BELANGER, AJ ;

GAGNON, DR .

AMERICAN HEART JOURNAL, 1990, 120 (03) :672-676

[8] GLYCOSAMINOGLYCANS AND THEIR BINDING TO BIOLOGICAL MACROMOLECULES [J].

LINDAHL, U ;

HOOK, M .

ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 :385-417

[9] IS THE IMBALANCE BETWEEN THROMBIN AND PLASMIN ACTIVITY IN DIABETES RELATED TO THE BEHAVIOR OF ANTIPLASMIN ACTIVITY [J].

MARONGIU, F ;

CONTI, M ;

MAMELI, G ;

SORANO, GG ;

COSSU, E ;

CIRILLO, R ;

BALESTRIERI, A .

THROMBOSIS RESEARCH, 1990, 58 (02) :91-99

[10]

MARONGIU F, 1995, THROMB HAEMOSTASIS, V74, P805

← 1 2 →